Clinical Trials › NCT06430671
Active, Not RecruitingPhase 1
Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis
Sponsored by Cellerys AG
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 11
Target enrollment
Jun 2024
Start date
Dec 2025
Expected completion
Interventions / Treatments
CLS12311 lowCLS12311 mediumCLS12311 highuncoupled RBCs
Conditions studied
Relapsing-remitting Multiple Sclerosis (RRMS)
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
More Phase 1 trials
Browse all Phase 1 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.